Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer
CONCLUSION: In our small dataset, 5-fraction, high-conformal ultrahypofractionated breast RT offered promising 2-year local control with minimal toxicity. Further studies are warranted to investigate the optimal dose and role in this setting.PMID:38529591 | DOI:10.4048/jbc.2024.0004
Source: Journal of Breast Cancer - Category: Cancer & Oncology Authors: Jeongshim Lee Jee Hung Kim Mitchell Liu Andrew Bang Robert Olson Jee Suk Chang Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Radiation Therapy | Skin | Study | Toxicology